首页 | 本学科首页   官方微博 | 高级检索  
检索        


Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy
Institution:1. Liver Unit, Internal Medicine Department, Hospital Universitari Vall d’Hebron, Passeig Vall d''Hebron 119-129, General Hospital, 5th floor, Barcelona 08035, Spain;2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain;1. Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, 702 Rotary Circle, Indianapolis, IN 46202, USA;2. Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;3. Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA;4. Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA;1. Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, Annenberg Building Room 5-12, New York, NY 10029, USA;2. Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, Recanati/Miller Transplantation Institute, 5 East 98th Street, New York, NY 10029, USA;1. Department of Nephrology, Ochsner Health, New Orleans, LA, USA;2. The University of Queensland/Ochsner Clinical School, Brisbane, Queensland, Australia
Abstract:
Keywords:Hepatitis B  Tenofovir alafenomide (TAF)  Therapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号